Drug intelligence / Profile preview

tramadol + acetaminophen

Development stage
Unknown
Lead developer
Daewon Pharm
Modality
Small Molecules
Administration
Oral
01

Overview

Wontran CR Tab is a fixed-dose combination of **tramadol hydrochloride**, a centrally acting opioid analgesic, and **acetaminophen** (paracetamol), a non-opioid analgesic and antipyretic. Developed by **Daewon Pharm**, it is formulated as a controlled-release tablet designed to provide sustained pain relief for moderate to severe acute and chronic pain. Tramadol exerts its effects as a mu-opioid receptor agonist and a weak inhibitor of norepinephrine and serotonin reuptake, while acetaminophen's mechanism primarily involves the inhibition of prostaglandin synthesis in the central nervous system. This combination leverages synergistic effects to improve analgesic efficacy while potentially reducing the required dose of the opioid component, thereby minimizing opioid-related side effects. The controlled-release formulation allows for less frequent dosing compared to immediate-release versions, improving patient compliance in chronic pain management.

Brand names
Wontran CR TabWontran CRWontran ER TabWontran
Other names
tramadol hydrochloride + acetaminophentramadol/acetaminophen CRtramadol/paracetamol ER
02

Targets

SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)MOR (Mu opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on tramadol + acetaminophen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tramadol + acetaminophen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call